Supplier Type
- Reagent
- Manufacturer
- Trader
- custom synthesis
- contract manufacturer
Supplier Region
- Ahmedabad(5)
- Mumbai(21)
- Hyderabad(32)
- Gujarat(18)
- Maharashtra(14)
- New Delhi(3)
- Andhra Pradesh(1)
- Tamil Nadu(1)
- Bangalore(3)
- Telangana(2)
- Pune(2)
- Delhi(3)
- Karnataka(5)
- Haryana(1)
- Beijing(1)
- Mallapur(1)
- Nagpur(1)
- Punjab(1)
Purity
- Salicylic Acid
- Rasagiline Mesylate Impurity C
- NLT 95%
- NLT 90%
- more than 95%
- more than 90%
- Mesalazine EP Impurity H
- Mathadone (M225865) impurity. Used in synthesis of methadone, antispasmodics and other pharmaceutica
- Greater than 99%
- Dipropargyl r- amino indane
- Dapagliflozin Intermediate, Dapagliflozin Impurity
- API Impurity / In-house working standard
- Acetylsalicylic Acid EP Impurity C
- ABOVE 99%
- 99-100%
- 99.98%
- 99.97%
- 99.95%
- 99.91%
- 99.90%
- 99.9%
- 99.89%
- 99.86%
- 99.85%
- 99.82%
- 99.81%
- 99.80%
- 99.73%
- 99.70%
- 99.52%
- 99.5 %
- 99.49%
- 99.45%
- 99.43%
- 99.42%
- 99.30%
- 99.29%
- 99.28%
- 99.27%
- 99.0% MIN
- 99%
- >99%
- > 99%
- 98+
- 98.90%
- 98.86%
- 98.60%
- 98.30%
- 98.20%
- 98.18%
- 98.12%
- 98.04%
- 98.00%
- 98%
- 98 %
- 97-99%
- 97.76%
- 97.57%
- 97.00%
- >97%
- 97%
- 97 %
- 96-98%
- 96.80%
- 96.39%
- 96.00%
- 96%
- 95-98%
- 95.00%
- 95%
- >95%
- 94.00%
- 93.21%
- >92%
- 91.41%
- 90%
- >90%
- 90 % Min.
- 90 % Above
- 25 MG 50 MG 100 MG 250 MG EXTRA
- 1.0M
- 0.5M
- (R)-N,N-di(prop-2-yn-1-yl)-2,3- dihydro-1
Package
- 2.5501e+00925 MG 50 MG 100 MG 250 MG EXTRA
- 25mg
- 50mg
- 100mg
- 250mg
- 500mg
- 1000mg
- 1g
- 1gm
- 5g
- 10g
- 25g
- 50g
- 100ml
- 100g
- 500g
- 500ml
- 1kg
- 1L
- 5kg
- 10kg
- 25kg
- 50kg
- 100kg
- 500kg
- 1000kg
- 1MT
- 1and gm
- 95NLT %
- 250250 mg.
-
Sofosbuvir IMpurity
1520010-86-9
-
Sofosbuvir Impurity22
-
1-((2S,3R,4R,5R)-3-fluoro-4-hydroxy-5-(hydroxymethyl)-3-methyltetrahydrofuran-2-yl)pyrimidine-2,4(1H,3H)-dione
2041584-99-8
-
Sofosbuvir Impurity 113
1987946-79-1
-
(S)-ethyl 2-(((S)-(perfluorophenoxy)(phenoxy)phosphoryl)amino)propanoate
1392015-05-2
-
(R)-isopropyl 2-(((R)-(perfluorophenoxy)(phenoxy)phosphoryl)amino)propanoate
1627824-09-2
-
2'-C-Methyl-, 2',3',5'-tribenzoateuridine
23643-36-9
-
(S)-methyl 2-(((S)-(((2R,3R,4R,5R)-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-4-fluoro-3-hydroxy-4-methyltetrahydrofuran-2-yl)methoxy)(phenoxy)phosphoryl)amino)propanoate
1394157-34-6
-
(R)-isopropyl 2-(((S)-(perfluorophenoxy)(phenoxy)phosphoryl)aMino)propanoate
1714114-25-6
-
Ketorolac EP IMpurity D
1391053-45-4
2-Methoxy-5-nitroaniline hydrochloride 67827-72-9
4-chloro-3-methoxy-2-methylpyridine-N-oxide 122307-41-9
Methyl 3-{[(2-Methoxy-2-oxoethyl)amino]sulfonyl}thiophene-2-carboxylate 106820-63-7
5-[(2R)-2-Aminopropyl]-2-methoxy benzene sulfonamide 112101-81-2
Carvedilol EP Impurity B 918903-20-5
(R)-(-)-5-(2-Aminopropyl)-2- methoxy benzene sulfonamide 112101-81-2
4-Chloro-2-Methoxy Pyrimidine 51421-99-9